These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14596076)

  • 21. Viral hepatitis and hepatocellular carcinoma.
    Marrero CR; Marrero JA
    Arch Med Res; 2007 Aug; 38(6):612-20. PubMed ID: 17613352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gastrointestinal bleeding, cryoglobulinemia, and hepatitis C.
    Fine GD; Trainer TD; Krawitt EL
    Am J Gastroenterol; 2004 May; 99(5):964-5. PubMed ID: 15128376
    [No Abstract]   [Full Text] [Related]  

  • 23. Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers.
    Islam S; Antonsson L; Westin J; Lagging M
    Scand J Gastroenterol; 2005 Jul; 40(7):867-72. PubMed ID: 16109665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The APRI and the RVR.
    Snyder N; Petersen JR
    J Clin Gastroenterol; 2009; 43(5):500-1. PubMed ID: 19098684
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical significance of metabolic syndrome in the setting of chronic hepatitis C virus infection.
    Hanouneh IA; Feldstein AE; Lopez R; Yerian L; Pillai A; Zein CO; Zein NN
    Clin Gastroenterol Hepatol; 2008 May; 6(5):584-9. PubMed ID: 18455698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent hepatitis C posttransplant: early preservation injury may predict poor outcome.
    Watt KD; Lyden ER; Gulizia JM; McCashland TM
    Liver Transpl; 2006 Jan; 12(1):134-9. PubMed ID: 16382465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Watch co-infected patients more closely.
    AIDS Patient Care STDS; 2005 Apr; 19(4):272. PubMed ID: 15857199
    [No Abstract]   [Full Text] [Related]  

  • 28. Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index.
    Sud A; Hui JM; Farrell GC; Bandara P; Kench JG; Fung C; Lin R; Samarasinghe D; Liddle C; McCaughan GW; George J
    Hepatology; 2004 May; 39(5):1239-47. PubMed ID: 15122752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Late sequelae of HCV infection].
    Wawrzynowicz-Syczewska M
    Przegl Epidemiol; 2008; 62(4):777-83. PubMed ID: 19209740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features of patients with HCC who are negative for both HBV and HCV markers.
    Watabe H; Shiratori Y; Tateishi R; Fujishima T; Akamatsu M; Koike Y; Obi S; Hamamura K; Sato S; Teratani T; Shiina S; Omata M
    Hepatogastroenterology; 2003; 50(54):2157-60. PubMed ID: 14696486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.
    Rodríguez-Díaz JL; Rosas-Camargo V; Vega-Vega O; Morales-Espinosa D; Mendez-Reguera A; Martínez-Tlahuel JL; Gamboa-Domínguez A; Arrieta O
    Clin Oncol (R Coll Radiol); 2007 Apr; 19(3):197-203. PubMed ID: 17359907
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma.
    Cantarini MC; Trevisani F; Morselli-Labate AM; Rapaccini G; Farinati F; Del Poggio P; Di Nolfo MA; Benvegnù L; Zoli M; Borzio F; Bernardi M;
    Am J Gastroenterol; 2006 Jan; 101(1):91-8. PubMed ID: 16405539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The natural history of compensated cirrhosis due to hepatitis C virus: A 17-year cohort study of 214 patients.
    Sangiovanni A; Prati GM; Fasani P; Ronchi G; Romeo R; Manini M; Del Ninno E; Morabito A; Colombo M
    Hepatology; 2006 Jun; 43(6):1303-10. PubMed ID: 16729298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Killer cell immunoglobulin-like receptor genotype and killer cell immunoglobulin-like receptor-human leukocyte antigen C ligand compatibility affect the severity of hepatitis C virus recurrence after liver transplantation.
    de Arias AE; Haworth SE; Belli LS; Burra P; Pinzello G; Vangeli M; Minola E; Guido M; Boccagni P; De Feo TM; Torelli R; Cardillo M; Scalamogna M; Poli F
    Liver Transpl; 2009 Apr; 15(4):390-9. PubMed ID: 19326408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ongoing management of hepatitis C.
    Harley H; Shaw D; Steven I
    Aust Fam Physician; 2003 Oct; 32(10):820-5. PubMed ID: 14596079
    [No Abstract]   [Full Text] [Related]  

  • 36. Noninvasive diagnosis of cirrhosis in chronic hepatitis C based on standard laboratory tests.
    Lackner C; Struber G; Bankuti C; Bauer B; Stauber RE
    Hepatology; 2006 Feb; 43(2):378-9; author reply 379. PubMed ID: 16440344
    [No Abstract]   [Full Text] [Related]  

  • 37. [Chronic hepatitis C virus infection and associated liver disease among the inmates of a Spanish prison].
    Murcia J; Portilla J; Bedia M; Palazón JM; Sánchez-Payá J; Saiz de la Hoya P; Payá A; Boix V; Merino E; Reus S
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):206-12. PubMed ID: 19246126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alcohol in hepatocellular cancer.
    Voigt MD
    Clin Liver Dis; 2005 Feb; 9(1):151-69. PubMed ID: 15763234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Assessing high risk group of patients for liver neoplasms by pathological findings].
    Yamada G
    Nihon Naika Gakkai Zasshi; 1995 Dec; 84(12):1970-4. PubMed ID: 8586915
    [No Abstract]   [Full Text] [Related]  

  • 40. Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan.
    Tseng TC; Liu CJ; Chen PJ; Lai MY; Lin CL; Kao JH; Chen DS
    Liver Int; 2007 Sep; 27(7):983-8. PubMed ID: 17696938
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.